This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Radiologic Scoring of Patients With Chronic Sinusitis and Nasal Polyps

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by Heba Abdel aal Mekhamar Abdel aal, Assiut University
Sponsor:
Information provided by (Responsible Party):
Heba Abdel aal Mekhamar Abdel aal, Assiut University
ClinicalTrials.gov Identifier:
NCT03174483
First received: May 31, 2017
Last updated: NA
Last verified: May 2017
History: No changes posted
  Purpose
To detect the effect of hypertonic saline and fluticasone sprays on computed tomography scan of paranasal sinuses of patients having chronic sinusitis and/or nasal polyps.

Condition Intervention
Chronic Sinusitis Drug: Hypertonic saline Drug: Fluticasone Nasal

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Hypertonic Saline and Fluticasone Nasal Sprays on Radiologic Scoring of Patients With Chronic Sinusitis and Nasal Polyps

Resource links provided by NLM:


Further study details as provided by Heba Abdel aal Mekhamar Abdel aal, Assiut University:

Primary Outcome Measures:
  • The percentage of patient with normal radiological scoring [ Time Frame: 1 month ]
    the score used is Lund Mackay radiological scoring


Estimated Enrollment: 60
Anticipated Study Start Date: June 2017
Estimated Study Completion Date: July 2018
Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: hypertonic saline
nasal spray will be used twice daily
Drug: Hypertonic saline
nasal spray
Active Comparator: fluticasone
nasal spray will be used once daily
Drug: Fluticasone Nasal
nasal spray

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients with chronic sinusitis and/or nasal polyps.

Exclusion Criteria:

  • Patients with previous nasal or sinus surgery.
  • Patients with sinonasal Malignancy.
  • Immunocompromised patients.
  • Patients with ciliary motility disorders.
  • Pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03174483

Contacts
Contact: Hussein Weshahy, MD 00201001775898 weshahy_orl@aun.edu.eg
Contact: Mohammad Osman, MD 00201005267182 mohamedosman@aun.edu.eg

Locations
Egypt
Assiut University Recruiting
Assiut, Egypt
Contact: Heba Abdel aal, MBBCh    00201119125556    happydocotor777@gmail.com   
Sponsors and Collaborators
Assiut University
  More Information

Responsible Party: Heba Abdel aal Mekhamar Abdel aal, principal investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03174483     History of Changes
Other Study ID Numbers: HSCS
Study First Received: May 31, 2017
Last Updated: May 31, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Sinusitis
Nasal Polyps
Chronic Disease
Paranasal Sinus Diseases
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Polyps
Pathological Conditions, Anatomical
Disease Attributes
Pathologic Processes
Fluticasone
Anti-Inflammatory Agents
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Asthmatic Agents
Respiratory System Agents
Dermatologic Agents
Anti-Allergic Agents

ClinicalTrials.gov processed this record on September 21, 2017